N.N. Blokhin National Medical Research Center of Oncology
Welcome,         Profile    Billing    Logout  
 5 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Matveev, Vsevolod B
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
Zhukova, Ludmila G
FERMATA, NCT03912415 / 2019-000623-40: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer

Recruiting
3
316
RoW
BCD-100, Bevacizumab, Paclitaxel, Cisplatin (or Carboplatin), Placebo
Biocad
Cervical Cancer
12/24
12/24
OBERTON, NCT03913923: Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

Active, not recruiting
2
117
RoW
BCD-217, BCD-100, Placebo
Biocad
Melanoma, Melanoma Metastatic
07/23
12/23
NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Completed
1
21
RoW
Stimotimagene copolymerplasmid, AntioncoRAN-M, Ganciclovir, Cymeven®
Gene Surgery LLC
Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms
04/24
04/24
Orlova, Kristina V
UNIVERSE, NCT06640530: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin

Recruiting
3
392
RoW
BCD-263, Nivolumab, Opdivo
Biocad
Advanced Melanoma, Melanoma (Skin)
12/25
03/27
NCT06112808: A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

Recruiting
1
300
RoW
BCD-263, Nivolumab, Opdivo
Biocad
Advanced Melanoma
09/24
01/27
Abouhaidar, Omar
No trials found
Akhmedov, Parvin
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Matveev, Vsevolod B
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
Zhukova, Ludmila G
FERMATA, NCT03912415 / 2019-000623-40: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer

Recruiting
3
316
RoW
BCD-100, Bevacizumab, Paclitaxel, Cisplatin (or Carboplatin), Placebo
Biocad
Cervical Cancer
12/24
12/24
OBERTON, NCT03913923: Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma

Active, not recruiting
2
117
RoW
BCD-217, BCD-100, Placebo
Biocad
Melanoma, Melanoma Metastatic
07/23
12/23
NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Completed
1
21
RoW
Stimotimagene copolymerplasmid, AntioncoRAN-M, Ganciclovir, Cymeven®
Gene Surgery LLC
Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms
04/24
04/24
Orlova, Kristina V
UNIVERSE, NCT06640530: Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® As Monotherapy in Subjects with Advanced Melanoma of the Skin

Recruiting
3
392
RoW
BCD-263, Nivolumab, Opdivo
Biocad
Advanced Melanoma, Melanoma (Skin)
12/25
03/27
NCT06112808: A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

Recruiting
1
300
RoW
BCD-263, Nivolumab, Opdivo
Biocad
Advanced Melanoma
09/24
01/27
Abouhaidar, Omar
No trials found
Akhmedov, Parvin
No trials found

Download Options